Patient Characteristics and Baseline Scores in 186Re-Etidronate Group Compared with Placebo Group
| Variable | Treatment group | P | ||
|---|---|---|---|---|
| 186Re-etidronate (n = 43) | Placebo (n = 36) | |||
| Age (y) | 70.0 ± 8.3 | 69.2 ± 7.4 | NS | |
| Weight (kg) | 78.2 ± 9.9 | 80.7 ± 10.5 | NS | |
| Height (m) | 1.78 ± 0.06 | 1.79 ± 0.06 | NS | |
| Bone scan index | 46.9 ± 27.5 | 47.4 ± 20.2 | NS | |
| Prostate-specific antigen (μg/L) | 332.7 ± 420.4 | 365.5 ± 648.6 | NS | |
| Baseline pretreatment scores | ||||
| Visual analog score | 45.3 ± 24.8 | 43.2 ± 23.0 | NS | |
| Daily activity score | 13.4 ± 5.4 | 14.0 ± 4.6 | NS | |
| Medication index | 1.9 ± 5.0 | 1.4 ± 1.5 | NS | |
NS = not statistically significant, P > 0.05.
Data are mean ± SD.